Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05316337 · ClinicalTrials.gov registry record · NA

Withings ECG-Monitor Study

A NA study of Atrial Fibrillation, sponsored by Withings.

Completed
Registry status
NA
Development phase
650
Enrollment target
10
Study locations

NCT05316337 is a NA study of Atrial Fibrillation that has completed, run by Withings. The registered enrollment target is 650 participants, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (78% lower). The trial reports 10 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05316337, a NA study of Atrial Fibrillation, has completed, sponsored by Withings.

COMPLETED
Registry status
NA
Development phase
650 participants
Enrollment target
10
Study locations

Study Summary

The aim of the study is to evaluate the performance of Withings WBS08 with embedded Withings ECG Monitor in the automatic detection of atrial fibrillation

Conditions Studied

Interventions

  • DEVICE Electrocardiogram recording

Study Locations (10)

Florida

  • FWD Clinical Research - Boca Raton
  • Florida Cardiovascular Research - Hialeah
  • Diverse Clinical Research - Miami
  • The Angel Medical Research - Miami Lakes

Texas

  • Texas Heart Institute - Houston
  • LINQ Research LLC - Pearland

Illinois

  • American Institute of Therapeutics - Lake Bluff

Louisiana

  • Cambridge Medical Trials - Alexandria

New York

  • Heartbeat Health - New York

Île-de-France Region

  • Henri-Mondor Hospital - Créteil

Trial Details

FieldValue
Enrollment Target 650 participants
Start Date 2022-07-15
Est. Completion 2023-09-01
Phase NA

Sponsor

Withings

5 total trials

What the Registry Record Tells You About NCT05316337

The ClinicalTrials.gov registry entry for NCT05316337 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (78% lower). The listed sponsor is Withings, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Electrocardiogram recording is the first listed.

NCT05316337 reports 10 study locations spanning 6 distinct geographic areas - top geographies include Florida, Texas, Illinois.

Frequently Asked Questions

What is clinical trial NCT05316337 about?

NCT05316337 is a clinical study titled "Withings ECG-Monitor Study". The aim of the study is to evaluate the performance of Withings WBS08 with embedded Withings ECG Monitor in the automatic detection of atrial fibrillation

What is the current status of trial NCT05316337?

This trial is currently completed. It is a NA study. The enrollment target is 650 participants. The study started on 2022-07-15. Estimated completion is 2023-09-01.

What conditions does trial NCT05316337 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT05316337?

The interventions under investigation include: Electrocardiogram recording (DEVICE).

Who is sponsoring clinical trial NCT05316337?

This trial is sponsored by Withings, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05316337 being conducted?

This trial has 10 study locations across Florida, Illinois, Louisiana, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.